Next Article in Journal
New Anticancer Drugs: Reliably Assessing “Value” While Addressing High Prices
Previous Article in Journal
Real-World Analysis of Post-Progression Treatment Patterns and Outcomes for EGFR Mutation-Positive Patients Treated with First-Line Osimertinib
 
 
Article

Article Versions Notes

Curr. Oncol. 2024, 31(5), 2441-2452; https://doi.org/10.3390/curroncol31050183
Action Date Notes Link
article xml file uploaded 28 April 2024 09:54 CEST Original file -
article xml uploaded. 28 April 2024 09:54 CEST Update https://www.mdpi.com/1718-7729/31/5/183/xml
article pdf uploaded. 28 April 2024 09:54 CEST Version of Record https://www.mdpi.com/1718-7729/31/5/183/pdf
article supplementary file uploaded. 28 April 2024 09:54 CEST - https://www.mdpi.com/1718-7729/31/5/183#supplementary
article html file updated 28 April 2024 09:56 CEST Original file https://www.mdpi.com/1718-7729/31/5/183/html
Back to TopTop